Blood Glucose Monitoring Market Size to Hit USD 25.53 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Blood Glucose Monitoring Market

5.1. COVID-19 Landscape: Blood Glucose Monitoring Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Blood Glucose Monitoring Market, By Product Type

8.1. Blood Glucose Monitoring Market Revenue and Volume, by Product Type

8.1.1. Self-Monitoring Blood Glucose (SMBG) Devices

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Continuous Glucose Monitoring (CGM) Systems

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Integrated/Smart Glucose Monitoring Devices

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Others

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Blood Glucose Monitoring Market, By Modality

9.1. Blood Glucose Monitoring Market Revenue and Volume, by Modality

9.1.1. Invasive

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Minimally Invasive

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Non-Invasive (Emerging)

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Blood Glucose Monitoring Market, By End User

10.1. Blood Glucose Monitoring Market Revenue and Volume, by End User

10.1.1. Hospitals & Clinics

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Home Care Settings

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Diagnostic Centers

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Ambulatory Surgical Centers

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Others (Rehabilitation Centers, Long-term Care Facilities)

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Blood Glucose Monitoring Market, By Patient Demographics

11.1. Blood Glucose Monitoring Market Revenue and Volume, by Patient Demographics

11.1.1. Type 1 Diabetes

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Type 2 Diabetes

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Gestational Diabetes

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Prediabetes / At-risk Population

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Others

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Blood Glucose Monitoring Market, By Distribution Channel

12.1. Blood Glucose Monitoring Market Revenue and Volume, by Distribution Channel

12.1.1. Hospital Pharmacies

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Retail Pharmacies

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Online Pharmacies

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Diabetes Clinics

12.1.4.1. Market Revenue and Volume Forecast

12.1.5. Others (Health & Wellness Chains, NGO Supply Channels)

12.1.5.1. Market Revenue and Volume Forecast

Chapter 13. Global Blood Glucose Monitoring Market, By Technology

13.1. Blood Glucose Monitoring Market Revenue and Volume, by Technology

13.1.1. Electrochemical Biosensors

13.1.1.1. Market Revenue and Volume Forecast

13.1.2. Optical Biosensors

13.1.2.1. Market Revenue and Volume Forecast

13.1.3. Microfluidics-based

13.1.3.1. Market Revenue and Volume Forecast

13.1.4. Wearable and AI-integrated

13.1.4.1. Market Revenue and Volume Forecast

13.1.5. Others (Infrared-based, Sweat/Saliva-based)

13.1.5.1. Market Revenue and Volume Forecast

Chapter 14. Global Blood Glucose Monitoring Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Volume Forecast, by Product Type

14.1.2. Market Revenue and Volume Forecast, by Modality

14.1.3. Market Revenue and Volume Forecast, by End User

14.1.4. Market Revenue and Volume Forecast, by Patient Demographics

14.1.5. Market Revenue and Volume Forecast, by Distribution Channel

14.1.6. Market Revenue and Volume Forecast, by Technology

14.1.7. U.S.

14.1.7.1. Market Revenue and Volume Forecast, by Product Type

14.1.7.2. Market Revenue and Volume Forecast, by Modality

14.1.7.3. Market Revenue and Volume Forecast, by End User

14.1.7.4. Market Revenue and Volume Forecast, by Patient Demographics

14.1.8. Market Revenue and Volume Forecast, by Distribution Channel

14.1.8.1. Market Revenue and Volume Forecast, by Technology

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Volume Forecast, by Product Type

14.1.9.2. Market Revenue and Volume Forecast, by Modality

14.1.9.3. Market Revenue and Volume Forecast, by End User

14.1.9.4. Market Revenue and Volume Forecast, by Patient Demographics

14.1.10. Market Revenue and Volume Forecast, by Distribution Channel

14.1.11. Market Revenue and Volume Forecast, by Technology

14.2. Europe

14.2.1. Market Revenue and Volume Forecast, by Product Type

14.2.2. Market Revenue and Volume Forecast, by Modality

14.2.3. Market Revenue and Volume Forecast, by End User

14.2.4. Market Revenue and Volume Forecast, by Patient Demographics

14.2.5. Market Revenue and Volume Forecast, by Distribution Channel

14.2.6. Market Revenue and Volume Forecast, by Technology

14.2.8. UK

14.2.8.1. Market Revenue and Volume Forecast, by Product Type

14.2.8.2. Market Revenue and Volume Forecast, by Modality

14.2.8.3. Market Revenue and Volume Forecast, by End User

14.2.9. Market Revenue and Volume Forecast, by Patient Demographics

14.2.10. Market Revenue and Volume Forecast, by Distribution Channel

14.2.10.1. Market Revenue and Volume Forecast, by Technology

14.2.11. Germany

14.2.11.1. Market Revenue and Volume Forecast, by Product Type

14.2.11.2. Market Revenue and Volume Forecast, by Modality

14.2.11.3. Market Revenue and Volume Forecast, by End User

14.2.12. Market Revenue and Volume Forecast, by Patient Demographics

14.2.13. Market Revenue and Volume Forecast, by Distribution Channel

14.2.14. Market Revenue and Volume Forecast, by Technology

14.2.15. France

14.2.15.1. Market Revenue and Volume Forecast, by Product Type

14.2.15.2. Market Revenue and Volume Forecast, by Modality

14.2.15.3. Market Revenue and Volume Forecast, by End User

14.2.15.4. Market Revenue and Volume Forecast, by Patient Demographics

14.2.16. Market Revenue and Volume Forecast, by Distribution Channel

14.2.16.1. Market Revenue and Volume Forecast, by Technology

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Volume Forecast, by Product Type

14.2.17.2. Market Revenue and Volume Forecast, by Modality

14.2.17.3. Market Revenue and Volume Forecast, by End User

14.2.17.4. Market Revenue and Volume Forecast, by Patient Demographics

14.2.18. Market Revenue and Volume Forecast, by Distribution Channel

14.2.18.1. Market Revenue and Volume Forecast, by Technology

14.3. APAC

14.3.1. Market Revenue and Volume Forecast, by Product Type

14.3.2. Market Revenue and Volume Forecast, by Modality

14.3.3. Market Revenue and Volume Forecast, by End User

14.3.4. Market Revenue and Volume Forecast, by Patient Demographics

14.3.5. Market Revenue and Volume Forecast, by Distribution Channel

14.3.6. Market Revenue and Volume Forecast, by Technology

14.3.7. India

14.3.7.1. Market Revenue and Volume Forecast, by Product Type

14.3.7.2. Market Revenue and Volume Forecast, by Modality

14.3.7.3. Market Revenue and Volume Forecast, by End User

14.3.7.4. Market Revenue and Volume Forecast, by Patient Demographics

14.3.8. Market Revenue and Volume Forecast, by Distribution Channel

14.3.9. Market Revenue and Volume Forecast, by Technology

14.3.10. China

14.3.10.1. Market Revenue and Volume Forecast, by Product Type

14.3.10.2. Market Revenue and Volume Forecast, by Modality

14.3.10.3. Market Revenue and Volume Forecast, by End User

14.3.10.4. Market Revenue and Volume Forecast, by Patient Demographics

14.3.11. Market Revenue and Volume Forecast, by Distribution Channel

14.3.11.1. Market Revenue and Volume Forecast, by Technology

14.3.12. Japan

14.3.12.1. Market Revenue and Volume Forecast, by Product Type

14.3.12.2. Market Revenue and Volume Forecast, by Modality

14.3.12.3. Market Revenue and Volume Forecast, by End User

14.3.12.4. Market Revenue and Volume Forecast, by Patient Demographics

14.3.12.5. Market Revenue and Volume Forecast, by Distribution Channel

14.3.12.6. Market Revenue and Volume Forecast, by Technology

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Volume Forecast, by Product Type

14.3.13.2. Market Revenue and Volume Forecast, by Modality

14.3.13.3. Market Revenue and Volume Forecast, by End User

14.3.13.4. Market Revenue and Volume Forecast, by Patient Demographics

14.3.13.5. Market Revenue and Volume Forecast, by Distribution Channel

14.3.13.6. Market Revenue and Volume Forecast, by Technology

14.4. MEA

14.4.1. Market Revenue and Volume Forecast, by Product Type

14.4.2. Market Revenue and Volume Forecast, by Modality

14.4.3. Market Revenue and Volume Forecast, by End User

14.4.4. Market Revenue and Volume Forecast, by Patient Demographics

14.4.5. Market Revenue and Volume Forecast, by Distribution Channel

14.4.6. Market Revenue and Volume Forecast, by Technology

14.4.7. GCC

14.4.7.1. Market Revenue and Volume Forecast, by Product Type

14.4.7.2. Market Revenue and Volume Forecast, by Modality

14.4.7.3. Market Revenue and Volume Forecast, by End User

14.4.7.4. Market Revenue and Volume Forecast, by Patient Demographics

14.4.8. Market Revenue and Volume Forecast, by Distribution Channel

14.4.9. Market Revenue and Volume Forecast, by Technology

14.4.10. North Africa

14.4.10.1. Market Revenue and Volume Forecast, by Product Type

14.4.10.2. Market Revenue and Volume Forecast, by Modality

14.4.10.3. Market Revenue and Volume Forecast, by End User

14.4.10.4. Market Revenue and Volume Forecast, by Patient Demographics

14.4.11. Market Revenue and Volume Forecast, by Distribution Channel

14.4.12. Market Revenue and Volume Forecast, by Technology

14.4.13. South Africa

14.4.13.1. Market Revenue and Volume Forecast, by Product Type

14.4.13.2. Market Revenue and Volume Forecast, by Modality

14.4.13.3. Market Revenue and Volume Forecast, by End User

14.4.13.4. Market Revenue and Volume Forecast, by Patient Demographics

14.4.13.5. Market Revenue and Volume Forecast, by Distribution Channel

14.4.13.6. Market Revenue and Volume Forecast, by Technology

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Volume Forecast, by Product Type

14.4.14.2. Market Revenue and Volume Forecast, by Modality

14.4.14.3. Market Revenue and Volume Forecast, by End User

14.4.14.4. Market Revenue and Volume Forecast, by Patient Demographics

14.4.14.5. Market Revenue and Volume Forecast, by Distribution Channel

14.4.14.6. Market Revenue and Volume Forecast, by Technology

14.5. Latin America

14.5.1. Market Revenue and Volume Forecast, by Product Type

14.5.2. Market Revenue and Volume Forecast, by Modality

14.5.3. Market Revenue and Volume Forecast, by End User

14.5.4. Market Revenue and Volume Forecast, by Patient Demographics

14.5.5. Market Revenue and Volume Forecast, by Distribution Channel

14.5.6. Market Revenue and Volume Forecast, by Technology

14.5.7. Brazil

14.5.7.1. Market Revenue and Volume Forecast, by Product Type

14.5.7.2. Market Revenue and Volume Forecast, by Modality

14.5.7.3. Market Revenue and Volume Forecast, by End User

14.5.7.4. Market Revenue and Volume Forecast, by Patient Demographics

14.5.8. Market Revenue and Volume Forecast, by Distribution Channel

14.5.8.1. Market Revenue and Volume Forecast, by Technology

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Volume Forecast, by Product Type

14.5.9.2. Market Revenue and Volume Forecast, by Modality

14.5.9.3. Market Revenue and Volume Forecast, by End User

14.5.9.4. Market Revenue and Volume Forecast, by Patient Demographics

14.5.9.5. Market Revenue and Volume Forecast, by Distribution Channel

14.5.9.6. Market Revenue and Volume Forecast, by Technology

Chapter 15. Company Profiles

15.1. Abbott Laboratories

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Acon Laboratories Inc.

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Arkray Inc.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Ascensia Diabetes Care

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. B. Braun Melsungen AG

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Bioptik Technology Inc.

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Dexcom Inc.

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. F. Hoffmann-La Roche AG

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. GlySens Incorporated

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. i-SENS Inc.

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The blood glucose monitoring market size is expected to increase from USD 16.46 billion in 2024 to USD 25.53 billion by 2034.

The blood glucose monitoring market is expected to grow at a compound annual growth rate (CAGR) of around 4.49% from 2025 to 2034.

The major players in the blood glucose monitoring market include Abbott Laboratories, Acon Laboratories Inc., Arkray Inc., Ascensia Diabetes Care, B. Braun Melsungen AG, Bioptik Technology Inc., Dexcom Inc., F. Hoffmann-La Roche AG, GlySens Incorporated, i-SENS Inc., LifeScan Inc., Medtronic plc, Nemaura Medical Inc., Nova Biomedical, Owen Mumford Ltd., Senseonics Holdings Inc., Sinocare Inc., Tandem Diabetes Care, Terumo Corporation, and Ypsomed Holding AG.

The driving factors of the blood glucose monitoring market are the advancements in technology and the rising prevalence of diabetes worldwide.

North America region will lead the global blood glucose monitoring market during the forecast period 2025 to 2034.